{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:02:40Z","timestamp":1787500960961,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10147-021-02020-9","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T09:02:37Z","timestamp":1630141357000},"page":"2331-2337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-5282","authenticated-orcid":false,"given":"Hidetaka","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ikki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fusegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Omi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiho","family":"Netsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumi","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Matoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanshiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Omatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tonooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kanao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"key":"2020_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333","journal-title":"J Clin Oncol"},{"key":"2020_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa029","author":"J Chen","year":"2020","unstructured":"Chen J, Bae E, Zhang L et al (2020) Penetrance of breast and ovarian cancer in women who carry a BRCA1\/2 mutation and do not use risk-reducing salpingo-oophorectomy: an updated meta-analysis. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/jncics\/pkaa029","journal-title":"JNCI Cancer Spectr"},{"key":"2020_CR3","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C et al (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30:2654\u20132663","journal-title":"J Clin Oncol"},{"key":"2020_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/ijgc-2019-000384","volume":"29","author":"T Enomoto","year":"2019","unstructured":"Enomoto T, Aoki D, Hattori K et al (2019) The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer genetic Testing of BRCA (CHARLOTTE). Int J Gynecol Cancer 29:1043\u20131049","journal-title":"Int J Gynecol Cancer"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jnci\/djs494","volume":"105","author":"JR McLaughlin","year":"2013","unstructured":"McLaughlin JR, Rosen B, Moody J et al (2013) Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2. J Natl Cancer Inst 105:141\u2013148","journal-title":"J Natl Cancer Inst"},{"key":"2020_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3332\/ecancer.2016.639.eCollection2016","volume":"10","author":"N Biglia","year":"2016","unstructured":"Biglia N, Sgandurra P, Bounous VE et al (2016) Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival. Ecancermedicalscience 10:639. https:\/\/doi.org\/10.3332\/ecancer.2016.639.eCollection2016","journal-title":"Ecancermedicalscience"},{"key":"2020_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13048-019-0511-7","volume":"12","author":"SI Kim","year":"2019","unstructured":"Kim SI, Lee M, Kim HS et al (2019) Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer. J Ovarian Res 12:40. https:\/\/doi.org\/10.1186\/s13048-019-0511-7","journal-title":"J Ovarian Res"},{"key":"2020_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ygyno.2015.11.009","volume":"140","author":"J Kotsopoulos","year":"2016","unstructured":"Kotsopoulos J, Rosen B, Fan I et al (2016) Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. Gynecol Oncol 140:42\u201347","journal-title":"Gynecol Oncol"},{"key":"2020_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","volume":"100","author":"RI Olivier","year":"2006","unstructured":"Olivier RI, Lubsen-Brandsma MA, Verhoef S et al (2006) CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol 100:20\u201326","journal-title":"Gynecol Oncol"},{"key":"2020_CR10","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.1200\/JCO.2005.05.097","volume":"23","author":"D Stirling","year":"2005","unstructured":"Stirling D, Evans DG, Pichert G et al (2005) Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international federation of gynecology and obstetrics system. J Clin Oncol 23:5586\u20135596","journal-title":"J Clin Oncol"},{"key":"2020_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/AOG.0b013e318238d030","volume":"118","author":"JR Jr van Nagell","year":"2011","unstructured":"van Nagell JR Jr, Miller RW, DeSimone CP et al (2011) Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol 118:1212\u20131221","journal-title":"Obstet Gynecol"},{"key":"2020_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967\u2013975","journal-title":"JAMA"},{"key":"2020_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"21","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 21:80\u201387","journal-title":"J Natl Cancer Inst"},{"key":"2020_CR14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","volume":"32","author":"AP Finch","year":"2014","unstructured":"Finch AP, Lubinski J, Moller P et al (2014) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 32:1547\u20131553","journal-title":"J Clin Oncol"},{"key":"2020_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","volume":"13","author":"Y Lee","year":"2006","unstructured":"Lee Y, Medeiros F, Kindelberger D et al (2006) Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol 13:1\u20137","journal-title":"Adv Anat Pathol"},{"key":"2020_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10147-019-01456-4","volume":"24","author":"H Nomura","year":"2019","unstructured":"Nomura H, Sekine M, Yokoyama S et al (2019) Clinical background and outcomes of risk-reducing salpingo-oophorectomy fir hereditary breast and ovarian cancers in Japan. Int J Clin Oncol 24:1105\u20131110","journal-title":"Int J Clin Oncol"},{"key":"2020_CR17","unstructured":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. Geneic\/Familyial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 1.2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf. Accessed 11 Jan 2021"},{"key":"2020_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","volume":"32","author":"C Garcia","year":"2014","unstructured":"Garcia C, Wendt J, Lyon L et al (2014) Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol 32:428\u2013433","journal-title":"Gynecol Oncol"},{"key":"2020_CR19","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e3","volume":"28","author":"YJ Lee","year":"2017","unstructured":"Lee YJ, Lee SW, Kim KR et al (2017) Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers. J Gynecol Oncol 28:e3. https:\/\/doi.org\/10.3802\/jgo.2017.28.e3","journal-title":"J Gynecol Oncol"},{"key":"2020_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jjco\/hyv190","volume":"46","author":"M Shigehiro","year":"2016","unstructured":"Shigehiro M, Kita M, Takeuchi S et al (2016) Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1\/2 mutation carriers in Japan: a preliminary report. Jpn J Clin Oncol 46:254\u2013259","journal-title":"Jpn J Clin Oncol"},{"key":"2020_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/jjco\/hyaa173","volume":"51","author":"Y Kobayashi","year":"2021","unstructured":"Kobayashi Y, Hirasawa A, Chiyoda T et al (2021) Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1\/2 pathogenic variant carriers among a cohort study in a single institution. Jpn J Clin Oncol 51:213\u2013217","journal-title":"Jpn J Clin Oncol"},{"key":"2020_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s10038-017-0355-1","volume":"64","author":"M Arai","year":"2018","unstructured":"Arai M, Yokoyama S, Watanabe C et al (2018) Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. J Hum Genet 64:447\u2013457","journal-title":"J Hum Genet"},{"key":"2020_CR23","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","volume":"32","author":"ME Sherman","year":"2014","unstructured":"Sherman ME, Piedmonte M, Mai PL et al (2014) Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from gynecologic oncology group trial GOG-0199. J Clin Oncol 32:3275\u20133283","journal-title":"J Clin Oncol"},{"key":"2020_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","volume":"21","author":"CB Powel","year":"2011","unstructured":"Powel CB, Chen LM, McLennan J et al (2011) Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer 21:846\u2013851","journal-title":"Int J Gynecol Cancer"},{"key":"2020_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaoncol.2016.1820","volume":"2","author":"CA Shu","year":"2016","unstructured":"Shu CA, Pike MC, Jotwani AR et al (2016) Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations. JAMA Oncol 2:1134\u20131140","journal-title":"JAMA Oncol"},{"key":"2020_CR26","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/cncr.31842","volume":"125","author":"Y Laitman","year":"2019","unstructured":"Laitman Y, Michaelson-Cohen R, Levi E et al (2019) Uterine cancer in Jewish Israeli BRCA1\/2 mutation carriers. Cancer 125:698\u2013703","journal-title":"Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-02020-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-021-02020-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-02020-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T21:03:12Z","timestamp":1636578192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-021-02020-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1007\/s10147-021-02020-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"9 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no disclosures for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}